Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
Soon after Trump revealed to the world that he has been taking the medicine, the White House doctor said the president is in good health.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
Data also show that several other leading domestic pharma companies have recalled their products from the US
The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.
Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
'We built it in the last three years and then one day, they came and they said you have to close it'
Sun Pharma's acquisition of Ranbaxy has once again revived evaluation of the troubled past of the latter, which had changed hands from the promoters merely five years ago.
The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.
the Maharashtra Food and Drug Administration on Saturday issued directives to various departments to cancel the licences of gutkha manufacturers, wholesalers and retailers in the state after finding magnesium carbonate in gutkha.
The US market for the drug is pegged at $1 billion. Cipla has been selling the product in the European market. It had won a similar case in the UK against GSK a couple of years ago.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
For Sun Pharma, it is an astute purchase that it hopes will not only boost its position in India but also globally.
These drugs will be entering in their global Phase -3 clinical trials early next year.
The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.
The outcome reaffirms the company's own testing and the long-standing assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, J&J said.
Amrita Singh scours the market for the smartest health devices going.
The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.
After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.
The pain relieving balm is made available at more than 1,000 retail stores in 75 different cities in 12 states in India
The tests, according to the report, showed that Pepsi products from its plant in Khalapur in Raigad district contained 0.6 mg of lindane, which is above the permissible limits.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
After Maggi, the sample of macroni pasta was taken from Mau and sent to National Food Analysis Laboratory.
Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
The new test it will enable rapid testing amongst more people easily.
The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.
The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.
There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.
Through a Freedom of Information Act request, the Show '20/20' obtained lists of recent health violation records from the FDA, the agency in charge of inspecting airlines and their outside food caterers.
Work to begin after that on corrective measures to meet US regulator's requirements.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances